BioSpace News Archive

Gov. Roy Cooper last week signed a bill amending North Carolina’s Drug Depository Program to broaden the availability of donated prescription drugs and allow free clinics to better serve people who are uninsured and underinsured.

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that effective July 1, 2019 it will commercialize the KLOR-CON® (potassium chloride) and Potassium Chloride product families and will continue its role as manufacturer.

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Company has been added as a member of the Russell 2000® and Russell 3000® Indexes effective at the opening of trading today, July 1, 2019.

Gelest, Inc., a leading innovator in materials science and a New Mountain Capital portfolio company, announced today the acquisition of Bimax, a manufacturer and marketer of specialty monomers and polymers for use in the manufacture of contact lenses, intraocular lenses, personal care products, coatings and adhesives, and other advanced technology applications.

Peer-reviewed journal article highlights unique oral delivery platform’s ability to enhance pharmacokinetic and therapeutic benefit for challenging drugs

ZULRESSO is the 11th FDA-approved drug to use Ligand’s patented Captisol technology.

This new addition brings AWG’s membership to 14 antimicrobial drug companies

Instem Company NOTOCORD Secures Portion of €4m Grant as Member of Exclusive Scientific Consortium Helping to Make Medications Safer

Orders Reflect Growing Interest across the Biotech Industry for Bacteria-Free, Plasmid-Free Therapies

Today, the company is at it again, dropping the price of myGenome from $999 to $599.